Articole cu mandate pentru acces public - Kirsten Elin Smith, Ph.D.Aflați mai multe
Nu este disponibil nicăieri: 1
An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations
CR McCurdy, A Sharma, KE Smith, CA Veltri, ST Weiss, CM White, ...
Expert Review of Clinical Pharmacology 17 (2), 131-142, 2024
Mandate: US National Institutes of Health
Disponibile undeva: 47
Kratom (Mitragyna speciosa): user demographics, use patterns, and implications for the opioid epidemic
A Garcia-Romeu, DJ Cox, KE Smith, KE Dunn, RR Griffiths
Drug and alcohol dependence 208, 107849, 2020
Mandate: US National Institutes of Health
Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use
KE Smith, JM Rogers, D Schriefer, O Grundmann
Drug and Alcohol Dependence 226, 108879, 2021
Mandate: US National Institutes of Health
Understanding kratom use: a guide for healthcare providers
MT Swogger, KE Smith, A Garcia-Romeu, O Grundmann, CA Veltri, ...
Frontiers in pharmacology 13, 801855, 2022
Mandate: US National Institutes of Health
Self-reported health diagnoses and demographic correlates with kratom use: results from an online survey
R Bath, T Bucholz, AF Buros, D Singh, KE Smith, CA Veltri, O Grundmann
Journal of addiction medicine 14 (3), 244-252, 2020
Mandate: US National Institutes of Health
The continued rise of methamphetamine use among people who use heroin in the United States
JC Strickland, WW Stoops, KE Dunn, KE Smith, JR Havens
Drug and alcohol dependence 225, 108750, 2021
Mandate: US National Institutes of Health
Kratom use as more than a “self-treatment”
KE Smith, KE Dunn, JM Rogers, O Grundmann, CR McCurdy, ...
The American journal of drug and alcohol abuse 48 (6), 684-694, 2022
Mandate: US National Institutes of Health
Social, psychological, and substance use characteristics of US adults who use kratom: Initial findings from an online, crowdsourced study.
KE Smith, KE Dunn, O Grundmann, A Garcia-Romeu, JM Rogers, ...
Experimental and clinical psychopharmacology 30 (6), 983, 2022
Mandate: US National Institutes of Health
Searching for a signal: self-reported kratom dose-effect relationships among a sample of US adults with regular kratom use histories
KE Smith, JM Rogers, KE Dunn, O Grundmann, CR McCurdy, D Schriefer, ...
Frontiers in Pharmacology 13, 765917, 2022
Mandate: US National Institutes of Health
Assessment of kratom use disorder and withdrawal among an online convenience sample of US adults
KE Smith, KE Dunn, JM Rogers, A Garcia-Romeu, JC Strickland, ...
Journal of addiction medicine 16 (6), 666-670, 2022
Mandate: US National Institutes of Health
When an obscurity becomes trend: social-media descriptions of tianeptine use and associated atypical drug use
KE Smith, JM Rogers, JC Strickland, DH Epstein
The American journal of drug and alcohol abuse 47 (4), 455-466, 2021
Mandate: US National Institutes of Health
A Facebook follow‐up strategy for rural drug‐using women
MF Dickson, M Staton‐Tindall, KE Smith, C Leukefeld, JM Webster, ...
The Journal of Rural Health 33 (3), 250-256, 2017
Mandate: US National Institutes of Health
Becoming a caregiver: experiences of young adults moving into family caregiving roles
ND Pope, PK Baldwin, A Gibson, K Smith
Journal of adult development 29 (2), 147-158, 2022
Mandate: US National Institutes of Health
Kratom use in the US: both a regional phenomenon and a white middle-class phenomenon? Evidence from NSDUH 2019 and an online convenience sample
JM Rogers, KE Smith, JC Strickland, DH Epstein
Frontiers in Pharmacology 12, 789075, 2021
Mandate: US National Institutes of Health
Examining the paradoxical effects of kratom: a narrative inquiry
KE Smith, JD Feldman, KE Dunn, CR McCurdy, ST Weiss, O Grundmann, ...
Frontiers in Pharmacology 14, 1174139, 2023
Mandate: US National Institutes of Health
Disease and decision
KE Smith
Journal of Substance Abuse Treatment 142, 108874, 2022
Mandate: US National Institutes of Health
Kratom use in the United States: a diverse and complex profile
O Grundmann, JK Babin, JE Henningfield, A Garcia-Romeu, AC Kruegel, ...
Addiction (Abingdon, England) 116 (1), 202, 2020
Mandate: US National Institutes of Health
Potential value of the insights and lived experiences of addiction researchers with addiction
SW Stull, KE Smith, NA Vest, DP Effinger, DH Epstein
Journal of addiction medicine 16 (2), 135-137, 2022
Mandate: US National Science Foundation, US National Institutes of Health
Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky
KE Smith, MD Tillson, M Staton, EM Winston
Drug and alcohol dependence 208, 107837, 2020
Mandate: US National Institutes of Health
Kratom alkaloids: a blueprint?
KE Smith, A Sharma, O Grundmann, CR McCurdy
ACS chemical neuroscience 14 (2), 195-197, 2023
Mandate: US National Institutes of Health
Informațiile despre publicații și finanțare sunt alese automat de un program informatic